(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid
Moexipril
CAS: 103775-10-6
Molecular Formula: C27H34N2O7
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid - Names and Identifiers
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid - Physico-chemical Properties
| Molecular Formula | C27H34N2O7 |
| Molar Mass | 498.57 |
| Density | 1?+-.0.06 g/cm3(Predicted) |
| Boling Point | 709.3±60.0 °C(Predicted) |
| Flash Point | 382.8°C |
| Vapor Presure | 4.1E-21mmHg at 25°C |
| pKa | 2.94±0.20(Predicted) |
| Refractive Index | 1.564 |
(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid - Reference Information
| effect | mosipril is well tolerated and usually has no significant effect on glucose, lipid and electrolyte metabolism and hemodynamic parameters. It is especially suitable for postmenopausal women. |
Last Update：2024-04-10 22:29:15
![(3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid](http://res.chembk.com/assets/str/2d/1/10/103775-10-6.png)